Company: LRHC
Filing Date: 2025-09-25
Form Type: S-1
Source: 0001213900-25-091637
Chunk: 52

Company: La Rosa Holdings Corp.
Filing Date: 2025-09-25
Form: S-1
Chunk 52
---
 cured by such date) or any
pro rata portion thereof, until the applicable Event Date is cured or sixty calendar days after the applicable Event Date, whichever comes
first, the Company shall pay to the Selling Stockholder an amount in cash, as partial liquidated damages, equal to the product of 2% multiplied
by the total purchase price of each outstanding Advance Notice; provided, that the maximum aggregate amount payable thereunder shall not
exceed 4% of such amount. The filing and effectiveness of the registration statement of which this Prospectus forms a part satisfies the
obligation of the Company under the Amended RRA to file and have declared effective by the SEC a registration statement covering the resale
of such Advance Shares.

Under the Amended RRA, the Company has granted
to and received from the Selling Stockholder customary indemnification rights in connection with the registration of Advance Shares under
the Amended RRA.

Stockholder Approval

The Company is currently listed on the Nasdaq
Capital Market and is subject to the listing rules of The Nasdaq Stock Market LLC. The issuance of the Shares implicate certain of the
Nasdaq listing standards requiring prior stockholder approval in order to maintain our listing on Nasdaq. On September 19, 2025, Joseph
La Rosa, the Company’s Chief Executive Officer, President and Chairman, and JLR-JCCLT1 Land Trust controlled by Mr. La Rosa, as
the stockholders holding majority of the voting power of the Company, in accordance with Nasdaq Listing Rules 5635(b) and 5635(d), approved
the entry into the Amended Facility Agreement and the transactions contemplated thereunder, including the issuance of the Shares, by written
consent in lieu of having a stockholders’ meeting. The Company has filed a preliminary information statement on Schedule 14C with
the SEC on September 19, 2025 notifying stockholders of such written consent. The Company is going to file a definitive statement on Schedule
14C with the SEC and commence mailing the definitive information statement to stockholders of record as of the close of business on September
29, 2025 before the effectiveness of the registration statement of which this Prospectus forms a part.

Pursuant to the terms of the Amended Facility
Agreement, issuance of Shares pursuant to the Facility in excess of 19.99% of the Company’s outstanding shares of common stock is
conditional upon obtaining the approval of the Company’s stockholders in